Related Experiment Video
Updated: Jul 12, 2026

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers
Published on: February 20, 2017
Current status of the taxanes as adjuvant therapy for breast cancer
Clifford Hudis1, Heather McArthur, Chau Dang
1Solid Tumor Division, Department of Medicine, Memorial Sloan-Kettering Cancer Center, MSKCC, 1275 York Avenue, New York, NY, USA. hudisc@mskcc.org
Abstract:
Adjuvant chemotherapy for breast cancer reduces the risks of recurrence and death in many subsets of patients. The quest for better regimens, defined as both more effective and less toxic has led to numerous clinical trials testing the taxanes in the adjuvant setting. These trials are generally positive but do not clearly identify a single best or ideal regimen for all patients. This paper reviews the available data in this area of clinical research.
Related Concept Videos
Drugs that Stabilize Microtubules
Treatment Resistent Cancers
Treatment Resistant Cancers
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
